January 27, 2021
Immunicum AB expanding its Netherlands R&D facilities in Leiden
Immunicum AB will move its in-house research and process development activities into a new facility at the Leiden Bio Science…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
January 27, 2021
Teneobio cleared for it’s treatment of mCRPC in USA
Teneobio, Inc. and its affiliate TeneoThree, Inc. announced today that their investigational new drug application (IND) for TNB-585, a bispecific T-cell engaging antibody for the treatment of metastatic castrate resistant prostate cancer (mCRPC) was cleared for the initiation of Phase I clinical studies by the US Food and Drug Administration (FDA) on January 23, 2021.
January 27, 2021
Promising therapy for menstrual pain tested by Myovant Sciences, Pfizer
Myovant Sciences and Pfizer said Monday that the Phase 3 SPIRIT long-term extension study of the investigational once-daily relugolix combination…
January 25, 2021
Moderna’s vaccine coming to India
Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.
January 20, 2021
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online.
January 15, 2021
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
LUXEMBOURG–(BUSINESS WIRE)–The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need…
December 22, 2020
Pfizer and BioNTech got positive opinion for their COVID-19 vaccine in EU
European Commission’s decision on conditional marketing authorization is expected imminently, after the positive CHMP opinion, which will make BNT162b2 if authorized, the first COVID-19 vaccine available in the European Union.
December 22, 2020
COVID-19: targeted treatment trial launched in Vienna
A phase II clinical trial of a treatment for COVID-19 patients is currently starting at the Medical University of Vienna as a sub-study of the Austrian CoronaVirus Adaptive Clinical Trial (ACOVACT), as an academia-industry collaboration (investigator Initiated trial) between Apogenix AG and its scientific consultant Henning Walczak and his teams at the University of Cologne and University College London (UCL).
December 21, 2020
Baris Erdogan takes over as CEO of Clinerion
Baris Erdogan, currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021. After a three-year tenure, Clinerion’s current CEO, Ian Rentsch, has decided to step down for personal reasons and to return to his family in Berlin by the end of January, 2021.
December 19, 2020
Moderna’s COVID-19 vaccine authorized in U.S.
U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.